尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Cote Jennifer. Insider active across 1 company, notably Harvard Bioscience INC. In total, 6 disclosures have been recorded. History available since 6 March 2023. The latest transaction was disclosed on 19 March 2025 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Cote Jennifer is a declarant linked to Harvard Bioscience INC, where she holds the role of Chief Financial Officer. She has 6 filings in total, and across the recent filings observed, the period runs from 2023-03-08 to 2025-03-21, with the dominant transaction nature shown as Tax withholding and buy and sell amounts of 0.